Back to Journals » Patient Intelligence » Volume 4

Support management in schizophrenia: a systematic review of current literature

Authors Pompili M, Montebovi, Forte, Palermo, Stefani, Telesforo, Campi, Giordano, Longo, Lamis D, Serafini G, Girardi P

Received 6 May 2012

Accepted for publication 25 October 2012

Published 17 December 2012 Volume 2012:4 Pages 79—101


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Maurizio Pompili,1 Franco Montebovi,1 Alberto Forte,1 Mario Palermo,1 Henry Stefani,1 Ludovica Telesforo,1 Sandra Campi,1 Gloria Giordano,1 Lucia Longo,1 Dorian A Lamis,2 Gianluca Serafini,1 Paolo Girardi1

1Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy; 2Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA

Background: Schizophrenia is generally considered a chronic disorder characterized by psychotic symptoms and relatively stable neurocognitive and interpersonal deficits. Antipsychotic medication has proven beneficial in reducing psychotic symptoms, but is often not enough to treat cognitive or functional impairments. Residual cognitive impairments are barriers to a patient’s full recovery from schizophrenia. Rehabilitation is an alternative and important approach which may be useful, and encompasses a variety of treatments including social skills training and psychoeducational and cognitive behavioral treatments.
Objective: To investigate the efficacy of psychosocial treatments in schizophrenia, evaluating its effects in the short and long term, comparing psychosocial treatments with pharmacotherapy, and assessing the effects of treatment and the main indications for use in patients with schizophrenia.
Methods: A careful MEDLINE®, Excerpta Medica, PsycLIT®, PsycINFO®, and Index Medicus search was performed to identify all papers and book chapters in English for the period 1970–2012.
Results: Findings from the studies included in this qualitative analysis suggest that social skills therapy, cognitive behavioral therapy, family intervention therapy, cognitive remediation therapy, and other nonpharmacological therapeutic strategies may be beneficial for patients with significant functional and symptomatic impairments.
Conclusion: Schizophrenic patients treated with nonpharmacological techniques have more rapid remission and relapse less frequently than patients treated only pharmacologically.

Keywords: schizophrenia, support management, nonpharmacological treatment, cognitive behavioral therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder

Pompili M, Venturini P, Innamorati M , Serafini G, Telesforo L, Lester D, Tatarelli R, Girardi P

Neuropsychiatric Disease and Treatment 2011, 7:259-265

Published Date: 6 May 2011

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension

Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al

Neuropsychiatric Disease and Treatment 2010, 6:633-638

Published Date: 22 September 2010

Patient outcome in migraine prophylaxis: the role of psychopharmacological agents

Maurizio Pompili, Gianluca Serafini, Marco Innamorati, et al

Patient Related Outcome Measures 2010, 1:107-118

Published Date: 17 September 2010

Psychiatric comorbidity and suicide risk in patients with chronic migraine

Maurizio Pompili, Gianluca Serafini, Daniela Di Cosimo, et al

Neuropsychiatric Disease and Treatment 2010, 6:81-91

Published Date: 1 April 2010

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?

Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al

Neuropsychiatric Disease and Treatment 2008, 4:247-255

Published Date: 8 February 2008

Readers of this article also read:

Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases

Tateiwa T, Takahashi Y, Ishida T, Kubo K, Masaoka T, Shishido T, Sano K, Yamamoto K

Therapeutics and Clinical Risk Management 2015, 11:1383-1389

Published Date: 15 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Managing hemophilia: the role of mobile technology

Khair K, Holland M

Smart Homecare Technology and TeleHealth 2014, 2:39-44

Published Date: 6 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010